Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...
In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...
Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...
Deutsche Bank analyst James Shin has maintained their bullish stance on LLY stock, giving a Buy rating on September 16. James Shin has given ...
Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...
“I am gobsmacked that Lilly is seeking confidential patient medical records to build a case against the very therapies that ...
Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...
The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...
As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up ...
Eli Lilly and Novo Nordisk the pharmaceutical heavyweights selling popular weight-loss injections are each dangling discounts to gain an edge and to ...